Neuromuscular disease--myasthenia gravis
Bufler, J.
MMW Fortschritte der Medizin 151(Suppl 4): 153-158
2010
ISSN/ISBN: 1438-3276 PMID: 21595142 Document Number: 646772
Document emailed within 1 workday
Related Documents
Pirskanen-Matell, R.; Matell, G.; Kalb, B.; Bjelak, S. 2000: Myasthenia gravis--an autoimmune neuromuscular disease Lakartidningen 97(41): 4594-4598Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Pirskanen, R. 1979: Myasthenia gravis and other neuromuscular diseases Duodecim; Laaketieteellinen Aikakauskirja 95(21): 1401-1411
Pühringer, F.K.; Rex, C.; Renner, M.; Kazmaier, F. 2001: Undiagnosed myasthenia gravis unmasked by neuromuscular blockade British Journal of Anaesthesia 87(4): 650-651
De Léan, J. 1983: Effects of plasmapheresis on neuromuscular transmission in myasthenia gravis L'Union Medicale du Canada 112(1): 9-13
Hohlfeld, R. 1990: Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission Laboratory Investigation; a Journal of Technical Methods and Pathology 62(3): 241-243
Nogués, M.A.; Rivero, A.; Stalberg, E. 1991: Single fiber electromyogram in myasthenia gravis and other neuromuscular diseases Medicina 51(4): 307-314
Jurenić, D.; Jusić, A. 1978: Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication) Neurologija 26(1-4): 37-39
Monsalve Naharro, J.A.; Gerónimo Pardo, M.; Ortiz Sánchez, V.E.; Pérez Valdivieso, J.M. 2011: Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis Revista Espanola de Anestesiologia y Reanimacion 58(10): 624-625
Tsujihata, M.; Hazama, R.; Ishii, N.; Ide, Y.; Takamori, M. 1979: Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases Rinsho Shinkeigaku 19(11): 751-759
Shibuya, N. 1978: A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes Rinsho Shinkeigaku 18(4): 177-184
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
Matsumoto, R.; Motomura, M.; Yoshimura, T.; Kohara, N.; Kato, T. 1999: Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy Rinsho Shinkeigaku 39(5): 531-537
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Csaplár, M.; Juhász, Márk.; Muzes, Görgyi.; Jakab, C.; Arányi, Z.; Rózsa, C.; Molnár, Béla.; Komoly, Sámuel.; Pápay, J.; Zágoni, Tás.; Herszényi, László.; Tulassay, Z. 2006: Association of coeliac disease and myasthenia gravis Orvosi Hetilap 147(18): 841-844
Mapelli, G.; De Palma, P.; Franco, F.; Fini, M. 1986: Optic neuritis with an autoimmune disease (myasthenia gravis) Acta Neurologica 8(2): 141-144
Malamud, S.W.; Blanco, H.; Luengo, B.; Torino, M.; Huberman, E.D. 1975: Myasthenia gravis and myocardiopathy. Double or single disease Revista Clinica Espanola 139(3): 283-286
Hohlfeld, R.; Wekerle, H. 1981: Myasthenia gravis. Prototype of an anti-receptor autoaggression disease Münchener Medizinische Wochenschrift 123(31): 1207-1211
Dawkins, R.L. 1975: Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia Clinical and Experimental Immunology 21(2): 185-201
Norman, R.A. 1984: Differential diagnosis of ptosis: report of a case of myasthenia gravis in a patient with diabetes and thyroid disease Journal of the American Osteopathic Association 83(7): 523-526